⌘K

Oncternal Therapeutics, Inc. (ONCT)

$1.68 1.52% $0.02 Healthcare

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T) product candidate that targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. Oncternal Therapeutics, Inc. has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. The company is headquartered in San Diego, California.

Market cap

$4.96M

CEO

Dr. James B. Breitmeyer M.D., Ph.D.

Full time employees

26.00

Headquarters

San Diego, CA

IPO Date

Feb 03, 2004

Price-to-earnings (PE) Ratio

-0.14

Earnings-per-share (EPS)

$-12.18

Cash ratio (TTM)

0.79

Current ratio (TTM)

2.89

Net profit margin (TTM)

-1,948.70%

PE ratio (TTM)

-0.12

PEG ratio (TTM)

-0.00

Price-to-book ratio (TTM)

0.28

Price-to-sales ratio (TTM)

2.37

Quick ratio (TTM)

2.89

Return on assets (TTM)

-150.77%

Return on equity (TTM)

120.03%

Similar stocks (15)

Nuvation Bio Inc.

NUVB

$3.00 3.28% $0.10

Neutral

Absci Corporation

ABSI

$4.23 6.28% $0.25

Downtrend

Instil Bio, Inc.

TIL

$65.38 -1.09% $-0.72

Uptrend

Adverum Biotechnologies, Inc.

ADVM

$7.56 8.15% $0.57

Downtrend

Assembly Biosciences, Inc.

ASMB

$18.50 1.82% $0.33

Uptrend

CytomX Therapeutics, Inc.

CTMX

$1.22 2.52% $0.03

Downtrend

Armata Pharmaceuticals, Inc.

ARMP

$2.25 7.14% $0.15

Downtrend

Passage Bio, Inc.

PASG

$0.70 0.29% $0.00

Downtrend

Kezar Life Sciences, Inc.

KZR

$0.58 0.57% $0.00

Downtrend

Protara Therapeutics, Inc.

TARA

$1.99 3.66% $0.07

Downtrend

Surrozen, Inc.

SRZN

$8.10 1.12% $0.09

Downtrend

Monopar Therapeutics Inc.

MNPR

$4.43 12.80% $0.49

Neutral

Vaccinex, Inc.

VCNX

$5.00 -3.29% $-0.17

Downtrend

Pasithea Therapeutics Corp.

KTTA

$5.19 -10.54% $-0.61

Downtrend

Aditxt, Inc.

ADTX

$0.45 1.79% $0.00

Downtrend

ETF Exposure (13)

Dimensional U.S. Targeted Value ETF

DFAT

5.4998e-4%

$55.73 1.69% $0.92

Uptrend

Dimensional U.S. Small Cap ETF

DFAS

4.058e-4%

$64.76 1.58% $1.01

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

3.438e-5%

$34.08 1.64% $0.55

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.43 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.42 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.42 -0.26% $-0.13

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$281.91 1.65% $4.56

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.71 1.88% $3.37

Uptrend

Downtrend

Similar stocks (15)

Nuvation Bio Inc.

NUVB

$3.00 3.28% $0.10

Neutral

Absci Corporation

ABSI

$4.23 6.28% $0.25

Downtrend

Instil Bio, Inc.

TIL

$65.38 -1.09% $-0.72

Uptrend

Adverum Biotechnologies, Inc.

ADVM

$7.56 8.15% $0.57

Downtrend

Assembly Biosciences, Inc.

ASMB

$18.50 1.82% $0.33

Uptrend

CytomX Therapeutics, Inc.

CTMX

$1.22 2.52% $0.03

Downtrend

Armata Pharmaceuticals, Inc.

ARMP

$2.25 7.14% $0.15

Downtrend

Passage Bio, Inc.

PASG

$0.70 0.29% $0.00

Downtrend

Kezar Life Sciences, Inc.

KZR

$0.58 0.57% $0.00

Downtrend

Protara Therapeutics, Inc.

TARA

$1.99 3.66% $0.07

Downtrend

Surrozen, Inc.

SRZN

$8.10 1.12% $0.09

Downtrend

Monopar Therapeutics Inc.

MNPR

$4.43 12.80% $0.49

Neutral

Vaccinex, Inc.

VCNX

$5.00 -3.29% $-0.17

Downtrend

Pasithea Therapeutics Corp.

KTTA

$5.19 -10.54% $-0.61

Downtrend

Aditxt, Inc.

ADTX

$0.45 1.79% $0.00

Downtrend

ETF Exposure (13)

Dimensional U.S. Targeted Value ETF

DFAT

5.4998e-4%

$55.73 1.69% $0.92

Uptrend

Dimensional U.S. Small Cap ETF

DFAS

4.058e-4%

$64.76 1.58% $1.01

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

3.438e-5%

$34.08 1.64% $0.55

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.43 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.42 -0.28% $-0.14

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.42 -0.26% $-0.13

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.13 -0.25% $-0.24

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.11 -0.25% $-0.24

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$281.91 1.65% $4.56

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.71 1.88% $3.37

Uptrend